Nicolede RosaMD
General Surgery • Omaha, NESurgical Oncology (Other than Breast)
VA Nebraska-Western Iowa Healthcare System Division Chief of General Surgery
Dr. de Rosa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4101 Woolworth Avenue
Omaha, NE 68105Phone+1 402-995-3709
Summary
- Nicole de Rosa, MD, based in Omaha, NE, is a specialist in General Surgery with a subspecialty in Surgical Oncology, excluding breast cancer. She completed her surgical residency at Duke University Hospital from 2010 to 2013 and a fellowship in Complex General Surgical Oncology at the University of Texas M D Anderson Cancer Center from 2013 to 2015. She graduated from Tufts University School of Medicine in 2006. Dr. de Rosa has published several research articles, notably on DNA mismatch repair deficiency in rectal cancer, melanoma immunotherapy, and anti-tumor immunity, with her works being widely cited.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2013 - 2015
Duke University HospitalResidency, Surgery, 2010 - 2013
Tufts University School of MedicineClass of 2006
Certifications & Licensure
NE State Medical License 2015 - 2026
TX State Medical License 2013 - 2016
NC State Medical License 2010 - 2013
American Board of Surgery Surgery- American Board of Surgery Complex General Surgical Oncology
Publications & Presentations
PubMed
- 77 citationsDNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer GeneticsNicole de Rosa, Miguel A. Rodriguez-Bigas, George J. Chang, Jula Veerapong, Ester Borras
Journal of Clinical Oncology. 2016-09-27 - 50 citationsMelanoma immunotherapy using mature DCs expressing the constitutive proteasomeJens Dannull, N. Rebecca Haley, Gary E. Archer, Smita K. Nair, David Boczkowski
The Journal of Clinical Investigation. 2013-07-01 - 34 citationsHazard-rate analysis and patterns of recurrence in early stage melanoma: moving towards a rationally designed surveillance strategy.April K.S. Salama, Nicole de Rosa, Randall P. Scheri, Scott K. Pruitt, James E. Herndon
Plos One. 2013-03-13
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
